A head-to-head comparison of sertindole and risperidone on metabolic parameters

Schizophr Res. 2010 Nov;123(2-3):276-7. doi: 10.1016/j.schres.2010.07.030. Epub 2010 Aug 21.
No abstract available

Publication types

  • Comparative Study
  • Letter
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Antipsychotic Agents / administration & dosage
  • Antipsychotic Agents / adverse effects*
  • Body Mass Index
  • Cholesterol / blood
  • Female
  • Humans
  • Imidazoles / administration & dosage
  • Imidazoles / adverse effects*
  • Indoles / administration & dosage
  • Indoles / adverse effects*
  • Lipids / blood
  • Male
  • Metabolic Syndrome / chemically induced*
  • Metabolic Syndrome / epidemiology
  • Middle Aged
  • Prospective Studies
  • Risperidone / administration & dosage
  • Risperidone / adverse effects*
  • Schizophrenia / diagnosis
  • Schizophrenia / drug therapy*
  • Schizophrenic Psychology
  • Treatment Outcome
  • Weight Gain / drug effects*

Substances

  • Antipsychotic Agents
  • Imidazoles
  • Indoles
  • Lipids
  • Cholesterol
  • sertindole
  • Risperidone

Associated data

  • ClinicalTrials.gov/NCT00856583